Skip to main content

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify Bellwether cases Agree to Settle

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify Bellwether cases Agree to Settle

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify  Bellwether cases Agree to Settle

Introduction

Judge Casey Rogers’ mediation efforts finally paid off as the parties involved in the first three Abilify-gambling bellwether cases agreed to settle the dispute before the scheduled June trials. The formal news was announced by the release of a court order issued by Judge Rogers on April 28 informing that the parties have agreed to settle, though the terms have not been disclosed. The order also states that ‘’the defendants Bristol-Myers Squibb and Otsuka Pharmaceuticals must pay the settlement proceeds to Plaintiffs and, in turn, Plaintiffs must execute full releases, at which time the trial dates will be removed from the Court’s docket.’’

The second round of early bellwether trials is expected to be scheduled soon by Judge Rodgers.

Over 800 Abilify lawsuits were centralized in October 2016 as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) in the U.S. District Court for the Northern District of Florida alleging that the defendants failed to warn the consumers and the medical community about the gambling risks associated with Abilify.

Superior Court Judge James De Luca is presiding over the cases filed in the parallel state court litigation established in New Jersey for which trials are expected to begin by the end of this year.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.